Ignite Creation Date:
2024-05-06 @ 8:28 PM
Last Modification Date:
2024-10-26 @ 3:28 PM
Study NCT ID:
NCT06397417
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-05-29
First Post:
2024-03-28
Brief Title:
Refractory Cardiac Arrest Treated on Field by ECMO
Sponsor:
Assistance Publique - Hôpitaux de Paris
Organization:
Assistance Publique - Hôpitaux de Paris
Study Overview
Official Title:
Prognosis of Refractory Out-of-hospital Cardiac Arrests Treated with Extracorporeal Cardiopulmonary Resuscitation ECMO by the Urgent Medical Aid Service SAMU of Paris
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
ReCATOBE
Brief Summary:
Out-of-hospital cardiac arrest without resumption of spontaneous circulatory activity despite advanced medical resuscitation is considered refractory Under certain well-defined conditions today in many cities around the world and particularly in Paris it benefits from resuscitation called ECPR extracorporeal cardiopulmonary resuscitation This technique consists of the installation of an extracorporeal membrane oxygenation ECMO device allowing organ perfusion while waiting for a resumption of cardiac activity Since 2011 the Paris SAMU SAMU 75 has set up a team capable of implementing ECPR for refractory out-of-hospital cardiac arrests This team based within the SAMU of Paris at the Necker hospital ECMO team composed of an emergency doctor or anesthesiologist-resuscitator a nurse anesthetist and an ambulance driver intervenes in Paris and its nearby region at the request of medical regulation Given the growing development of this activity it is essential to measure its effectiveness in real-life conditions
Detailed Description:
Out-of-hospital cardiac arrest without resumption of spontaneous circulatory activity despite advanced medical resuscitation is considered refractory Under certain well-defined conditions today in many cities around the world and particularly in Paris it benefits from resuscitation called ECPR extracorporeal cardiopulmonary resuscitation This technique consists of the installation of an extracorporeal membrane oxygenation ECMO device allowing organ perfusion while waiting for a resumption of cardiac activity Since 2011 the Paris SAMU SAMU 75 has set up a team capable of implementing ECPR for refractory out-of-hospital cardiac arrests This team based within the SAMU of Paris at the Necker hospital ECMO team composed of an emergency doctor or anesthesiologist-resuscitator a nurse anesthetist and an ambulance driver intervenes in Paris and its nearby region at the request of medical regulation Given the growing development of this activity it is essential to measure its effectiveness in real-life conditions
The study consists of establishing a prospective register over a period of 20 years of patients aged over 18 years victims of refractory non-traumatic out-of-hospital cardiac arrest in the coverage area of the ECMO TEAM of the Paris SAMU
The 1-year survival rate of patients will be measured the functional prognosis will be evaluated and a search for associated factors will be carried out Patients long-term cardiac function will be collected as well as the incidence of ECPR-related complications
The study consists of establishing a prospective register over a period of 20 years of patients aged over 18 years victims of refractory non-traumatic out-of-hospital cardiac arrest in the coverage area of the ECMO TEAM of the Paris SAMU
The 1-year survival rate of patients will be measured the functional prognosis will be evaluated and a search for associated factors will be carried out Patients long-term cardiac function will be collected as well as the incidence of ECPR-related complications
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None